APA (7th ed.) Citation

Abumiya, M., Takahashi, N., Takahashi, S., Yoshioka, T., Kameoka, Y., & Miura, M. (2021). Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy. Nature Portfolio.

Chicago Style (17th ed.) Citation

Abumiya, Maiko, Naoto Takahashi, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, and Masatomo Miura. Effects of SLC22A2 808G>T Polymorphism and Bosutinib Concentrations on Serum Creatinine in Patients with Chronic Myeloid Leukemia Receiving Bosutinib Therapy. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Abumiya, Maiko, et al. Effects of SLC22A2 808G>T Polymorphism and Bosutinib Concentrations on Serum Creatinine in Patients with Chronic Myeloid Leukemia Receiving Bosutinib Therapy. Nature Portfolio, 2021.